Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 10;5(9):834-836.
doi: 10.1002/bco2.407. eCollection 2024 Sep.

Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohort

Affiliations

Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohort

Thineskrishna Anbarasan et al. BJUI Compass. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744071 Free PMC article.
No abstract available

Keywords: ASAP; atypical small acinar proliferation; biopsy; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Lisa Browning receives funding for a study (ArticulatePro) evaluating Paige Prostate, which is funded by the NHSX Artificial Intelligence in Health and Care Award: Driving system‐wide improvements with real‐world economics evidence and subspecialist‐led adoption guidelines for full workflow implementation of AI with Paige Prostate cancer detection (Paige AI 2020, New York), grading and quantification tool in histopathology departments (AI_AWARD02269). Richard Colling is part funded by UKRI (WCT WVI MAP project and PathLAKE project in‐kind partnership with Philips), mdxhealth (research funding), NHSX (ARTICULATE PRO: evaluating Paige AI), and the Clarendon Fund (University of Oxford). Richard Bryant receives grant funding for TRANSLATE Trial (NIHR‐HTA: NIHR131233), PART Trial Funding (NIHR‐HTA: 17/150/01), Cancer Research Clinician Scientist Fellowship (A22748). Participates in STAMINA Trial Programme Steering Committee. Ian Roberts receives consulting fees from Novartis and Travere Therapeutics and support for attending meetings from American Society of Nephrology, International Academy of Pathology and Asia Pacific Society of Nephrology. Alastair Lamb receives grant funding for TRANSLATE Trial (NIHR‐HTA: NIHR131233). ADL was supported by a Cancer Research UK Clinician Scientist Fellowship award (C57899/A25812).

Similar articles

Cited by

  • Erratum.
    [No authors listed] [No authors listed] BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. eCollection 2024 Dec. BJUI Compass. 2024. PMID: 39744071 Free PMC article.

References

    1. Merrimen JL, Jones G, Hussein SAB, Leung CS, Kapusta LR, Srigley JR. A model to predict prostate cancer after atypical findings in initial prostate needle biopsy. J. Urol. 2011;185(4):1240–1245. 10.1016/j.juro.2010.11.063 - DOI - PubMed
    1. Kim H, Kim JK, Choe G, Hong SK. Clinical strategy of repeat biopsy in patients with atypical small acinar proliferation (ASAP). Sci. Rep. 2021;11(1):23143. 10.1038/s41598-021-02172-8 - DOI - PMC - PubMed
    1. Norman RD, Garg H, Rickborn L, Kaushik D, Pruthi DK, Mansour AM, et al. Clinically significant prostate cancer in men with high‐grade intraepithelial prostatic intraepithelial neoplasia or atypical small acinar proliferation. JU Open Plus. 2023;1(9). 10.1097/ju9.0000000000000050 - DOI
    1. EAU guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978‐94‐92671‐16‐5.
    1. Burks FN, Hu JC, Telang D, Liu A, Hawken S, Montgomery Z, et al. Repeat prostate biopsy practice patterns in a statewide quality improvement collaborative. J. Urol. 2017;198(2):322–328. 10.1016/j.juro.2017.02.3338 - DOI - PubMed

LinkOut - more resources